EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis
19 juil. 2024 16h15 HE
|
EDAP TMS S.A.
Robotic HIFU therapy continues to maintain an excellent safety profile, confirming positive safety data from prior Phase 1 and 2 studies in patients with deep infiltrating endometriosisAt...
EDAP Appoints Fran Schulz to Board of Directors
08 juil. 2024 07h00 HE
|
EDAP TMS S.A.
PDF Version LYON, France, July 8, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced the appointment of Fran Schulz to...
EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations
03 juin 2024 08h00 HE
|
EDAP TMS S.A.
New appointments bring significant commercial experience with a focus on growing key strategic markets Expands executive leadership in growing disruptive, robotics-based capital equipment in both...
HiberCell Announces First Patient Dosed in Phase 1b Clinical Trial, Evaluating HC-7366 in Combination with Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia (AML)
28 mai 2024 08h00 HE
|
HiberCell, Inc.
HiberCell Announces First Patient Dosed in Phase 1b Clinical Trial in AML, Evaluating HC-7366 in Combination with Venetoclax and Azacitidine
EDAP to Present at the Jefferies Global Healthcare Conference
22 mai 2024 08h00 HE
|
EDAP TMS S.A.
LYON, France, May 22, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled...
EDAP Reports First Quarter 2024 Financial Results
16 mai 2024 08h00 HE
|
EDAP TMS S.A.
Strong Q1 2024 U.S. Focal One® HIFU procedure growth of +92% year-over-year Q1 2024 HIFU revenue of EUR 5.8 million ($6.3 million USD), an increase of 10.2% over Q1 2023Q1 2024 total revenue...
Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as new Truveta Board of Directors Chair
13 mai 2024 09h00 HE
|
Truveta
BELLEVUE, Wash., May 13, 2024 (GLOBE NEWSWIRE) -- Today Truveta, a growing collective of more than 30 health systems with a mission of Saving Lives with Data, welcomes Rod Hochman, MD, president and...
LogicMark, Inc. to Present at Virtual Emerging Growth Conference on May 8, 2024
07 mai 2024 18h03 HE
|
LogicMark, Inc.
LOUISVILLE, K.Y., May 07, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK), a provider of personal emergency response systems (PERS), health communications devices, and technology for the...
EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting
06 mai 2024 08h00 HE
|
EDAP TMS S.A.
Final results demonstrate a significantly higher salvage treatment free survival rate (STFS) at 30 months of 89.6% in the HIFU-treated arm versus 86.2% in patients who...
Using clinical-led AI, Truveta expands clinical notes and medical images available to advance research
02 mai 2024 09h00 HE
|
Truveta
BELLEVUE, Wash., May 02, 2024 (GLOBE NEWSWIRE) -- Today Truveta announced the availability of expanded concepts from clinical notes -- including family history, medication details reported to...